Fahy Gurteen, a Dublin-based biotech business, has taken space at Cambridge Research Park in a move that strengthens the hub’s oncology credentials.
It has taken a six-year lease on 8,000 sq ft of laboratory and office space at Building 7300.
As a specialist in cancer research, Fahy Gurteen will be in good company at CRP, which is home to the UK headquarters of biotech firm Horizon Discovery Ltd.
Fahy Gurteen will take over the fully fitted laboratories recently vacated by Horizon, which has moved to the adjacent 17,500 sq ft Building 7100.
“The synergy of working alongside fellow researchers such as Horizon is just one advantage of being at CRP,” says John Hynes, director of Fahy Gurteen.
“Being able to step into ready-made, fully-fitted laboratories is another. Adding to that Cambridge’s reputation as an international biotech centre and the prime location makes this an ideal opportunity.”
Dominic Moore of landlord Mountgrange Real Estate Opportunity Fund said: “We are delighted to welcome Fahy Gurteen to the Park. Together with Horizon they’ll form the core of a new cluster working in cancer research and add to the park’s reputation as key centre for cutting edge biotech and hi-tech industries.”
A key attraction for fast growing companies at CRP is the range and flexibility of the accommodation on offer, which greatly facilitates on-site expansion.
In addition to leasehold options the landlords are offering pre-let and land sale options on 26 acres of development-ready land.